CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 30 enrolled
Drug / intervention
ADAM SPECT plus Cognitive Therapy +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00641108
NCT00641108Phase 3Completed
CompareCT.gov

Effect of Psychotherapy on Brain Serotonin Activity

University of Pennsylvania·interventional·Posted Mar 21, 2008·Updated Apr 16, 2020

In Brief

A Phase 3 clinical trial evaluating ADAM SPECT plus Cognitive Therapy and ADAM SPECT plus No Therapy for Depression. Completed, enrolled 30 participants across 1 site.

Detailed Summary

This study will examine changes in brain serotonin activity in people with depression before and after they receive cognitive behavioral therapy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDepression
CountriesUnited States
CollaboratorsNational Institute of Mental Health (NIMH)

Timeline

Phase 3CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMar 21, 2008
Enrollment StartJan 1, 2008
Primary CompletionDec 1, 2011
TodayJul 2, 2026
Enrollment to primary: 3.9 yearsPosted 18.3 years ago

Interventions

ADAM SPECT plus Cognitive Therapydrug

ADAM SPECT plus No Therapydrug